Continuous Positive Airway Pressure (CPAP) therapy is the primary treatment for obstructive sleep apnea (OSA). By delivering a constant stream of air, it prevents the airway collapse that causes intermittent hypoxia, a state of repeated oxygen deprivation that drives systemic inflammation, oxidative stress, and sympathetic nervous system overactivation. Mitigating these effects significantly reduces the risk of major age-related diseases, including hypertension, cardiovascular disease, stroke, and metabolic syndrome, thereby directly supporting healthspan.
Verdict
Essential for diagnosed sleep apnea; non-applicable for others.
HEALTHSPAN IMPACT
Foundational
RISK LEVEL
Very Low
EVIDENCE GRADE
A
MONTHLY COST
$500 - $1500
Protocol
- Used nightly during all sleep periods as prescribed by a physician following a sleep study.
Flags
- Requires a formal diagnosis of sleep apnea from a sleep study.
- Adherence and proper mask fit are critical for efficacy.
- Initial adjustment period can be challenging for some users.
- Regular cleaning of equipment is necessary to prevent respiratory infections.